文献速递脑血管病

镰状细胞特质与非洲裔美国人缺血性卒中的关联:一项Meta分析

Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis.
PubMed 文献 · JAMA Neurol · 2018-01-01

这项Meta分析纳入4项前瞻性人群研究的19464名非洲裔美国人,其中1520人携带镰状细胞特质(SCT)、620人发生缺血性卒中。校正主要卒中危险因素后,SCT与缺血性卒中的风险比为0.80(95%CI 0.47-1.35;P=.82),作者认为SCT可能与非裔美国人缺血性卒中的发生无关,建议对合并SCT的卒中患者进行更全面的临床评估,而非假定SCT为病因。

要点

  • 在19464名非洲裔美国人中,SCT与缺血性卒中的校正HR为0.80(95%CI 0.47-1.35;P=.82)。
  • SCT组缺血性卒中的粗发病率为2.9/1000人年,无SCT组为3.2/1000人年。
  • 作者认为SCT可能与非裔美国人缺血性卒中的发生无关。

核心结论

  • SCT可能与非裔美国人缺血性卒中的发生无关。
  • 作者建议对合并SCT的卒中患者进行更全面的临床评估,而非假定SCT是卒中的病因。

研究设计与样本

  • 这项Meta分析纳入4项大型前瞻性人群研究中的非洲裔美国人队列:杰克逊心脏研究(2005年9月1日至2012年12月31日)、多民族动脉粥样硬化研究(2002年7月1日至2012年12月31日)、卒中地理与种族差异原因研究(2003年1月1日至2014年12月31日)和妇女健康倡议(1998年10月1日至2012年12月31日)。
  • 共纳入19464名非洲裔美国人,其中1520人携带SCT、17944人不携带SCT,620人发生缺血性卒中;平均(SD)年龄为60.0(13.0)岁,男性5257人(27.0%)、女性14207人(73.0%)。
  • SCT状态通过聚合酶链反应测定基因分型或全外显子组测序联合填充确定,采用校正主要卒中危险因素的Cox比例风险回归模型估计SCT相关的新发缺血性卒中风险比。
  • 数据分析于2016年7月10日至2017年2月2日进行。

主要发现

  • 在各队列第1次研究访视时,携带与不携带SCT的参与者之间缺血性卒中危险因素的分布未见差异。
  • SCT组缺血性卒中的粗发病率为2.9/1000人年(95%CI 2.2-4.0/1000人年),无SCT组为3.2/1000人年(95%CI 2.7-3.8/1000人年)。
  • 校正卒中危险因素后,4个队列Meta分析中SCT独立相关的新发缺血性卒中风险比为0.80(95%CI 0.47-1.35;P=.82)。
  • Meta分析结果与各单独队列的结果相似,各单独队列的结果也相似。

关键数值与推荐

  • SCT组缺血性卒中的粗发病率为2.9/1000人年(95%CI 2.2-4.0/1000人年),无SCT组为3.2/1000人年(95%CI 2.7-3.8/1000人年)。
  • 校正卒中危险因素后,SCT与新发缺血性卒中的风险比为0.80(95%CI 0.47-1.35;P=.82)。

临床怎么用

  • 作者建议对合并SCT的卒中患者进行更全面的临床评估,而非假定SCT是卒中的病因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: African Americans and individuals of African ancestry have a higher risk of stroke compared with non-Hispanic white individuals. Identifying the source of this disparity could provide an opportunity for clinical stroke risk stratification and more targeted therapy. Whether sickle cell trait (SCT) is an indicator of increased risk of ischemic stroke among African Americans is still unclear. OBJECTIVE: To examine whether SCT is associated with a higher risk of incident ischemic stroke among African Americans. DESIGN, SETTING, AND PARTICIPANTS: This meta-analysis assessed the association of SCT with the risk of incident ischemic stroke. Four large, prospective, population-based studies with African American cohorts were assessed: Jackson Heart Study (September 1, 2005, through December 31, 2012), Multi-Ethnic Study of Atherosclerosis (July 1, 2002, through December 31, 2012), Reasons for Geographic and Racial Differences in Stroke (January 1, 2003, through December 31, 2014), and Women's Health Initiative (October 1, 1998, through December 31, 2012). Using a Cox proportional hazards regression model adjusted for major stroke risk factors, this study estimated the hazard ratio for incident ischemic stroke associated with SCT. Data analysis was performed from July 10, 2016, to February 2, 2017. INTERVENTIONS OR EXPOSURES: Participants' SCT status determined by polymerase chain reaction assay genotyping or a combination of whole-exome sequencing and imputation. MAIN OUTCOMES AND MEASURES: Incident ischemic stroke. RESULTS: This meta-analysis included 19 464 African American individuals (1520 with SCT, 17 944 without SCT, and 620 with ischemic stroke) from 4 studies, with a mean (SD) age of 60.0 (13.0) years (5257 [27.0%] men and 14 207 [73.0%] women). No differences were found in the distribution of risk factors for ischemic stroke comparing participants with and those without SCT at study visit 1 in each cohort. The crude incidence of ischemic stroke was 2.9 per 1000 person-years (95% CI, 2.2-4.0 per 1000 person-years) among those with SCT and 3.2 per 1000 person-years (95% CI, 2.7-3.8 per 1000 person-years) among those without SCT. After stroke risk factors were adjusted for, the hazard ratio of incident ischemic stroke independently associated with SCT in the meta-analysis of all 4 cohorts was 0.80 (95% CI, 0.47-1.35; P = .82). The results of the meta-analysis were similar to those of individual cohorts, in which the results were also similar. CONCLUSIONS AND RELEVANCE: Sickle cell trait may not be associated with incidence of ischemic stroke among African Americans. The results of this study suggest performing a more thorough clinical evaluation of a stroke patient with SCT rather than assuming that SCT is the etiologic factor for the stroke.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Hyacinth HI, Carty CL, Seals SR, et al. Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis. JAMA Neurol. 2018. PMID: 29710269. doi:10.1001/jamaneurol.2018.0571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。